Publishing translational & clinical investigations of human health & disease focusing on #endocrine neoplasias & hormone-dependent #cancers. Owned by @soc_endo.
- Tweets 2,063
- Following 1,448
- Followers 3,293
- Likes 1,190
ALT Register Now! 2025 Margie & Robert E. Petersen. Neuroendocrine Tumor Research Symposium. Breakthroughs today, cures tomorrow. Location: Boston, Massachusetts. Date: November 17-19.
ALT Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer in Endocrine-Related Cancer. By Vikki L Poole et al. Published by Bioscientifica. Society for Endocrinology. Figure 1. Phosphorylated PBF represses RAIU in breast cancer cells. (A) Left – schematic of the interaction between NIS and PBF proteins tagged at the C-terminus with the NanoLuc luciferase subunits LgBiT and SmBiT, respectively. In close proximity, LgBiT and SmBiT form a functional enzyme that uses the substrate furimazine to produce a high-intensity, luminescent signal. Created using Alphafold (59, 60) and BioRender. Right – NanoBiT analysis of NIS:PBF interaction in MCF-7 cells, with bar graph showing results at 20 min post-addition of Nano-Glo live cell assay substrate. (B) Co-immunoprecipitation assay showing PBF-HA and NIS-MYC interaction in MCF-7 breast cancer cells. (C) Schematic of PBF highlighting the overlapping phosphorylation site...Endocrine-Related Cancer 32, 8; 10.1530/ERC-24-0312
ALT Heme-oxygenase-1: a key player in thyroid carcinoma development in Endocrine-Related Cancer. By Exequiel Gonzalo Alonso et al. Graphical Abstract. Published by bioscientifica. Society for Endocrinology.
ALT Special Collection: Pituitary Tumours: Scientific Discoveries, Clinical Advances and Contested Paradigms. Endocrine-Related Cancer. Collection Editors: Dr. Sunita M. C. De Sousa, MD, PhD Dr. Frederic Castinetti, MD, PhD Dr. Henriett Butz, MD, PhD Dr. Adrian F. Daly, MD, PhD
ALT Follow us on LinkedIn. LinkedIn logo. Endocrine-Related Cancer logo.
ALT Endocrine-Related Cancer. Themed Collection: Systems Biology Approaches in Hormone Dependent Cancer Research. New Review: Systems biology successes and areas for opportunity in prostate cancer in Endocrine-Related Cancer. By Michael V Orman et al.
ALT Endocrine-Related Cancer. New Associate Editor. Professor Alfred Lam. Professor of Pathology, Griffith University, Australia. Latest Research: Rising incidence of follicular thyroid carcinoma and oncocytic carcinoma of the thyroid. By Steven Weller, Cordia Chu, and Alfred King-yin Lam
ALT The Nuclear Medicine Pilot Research Grant in Neuroendocrine Tumors (NETs). Submissions Now Open. Proposal Due August 31, 2025. ERF Logo. NETRF logo.
ALT DNA-PKcs inhibition as a therapeutic approach for differentiated thyroid cancer in Endocrine-Related Cancer. By Shu-Fu Lin et al. Society for Endocrinology, Published by bioscientifica.
ALT New Review in Emerging Leaders 2025 Special Collection. Impact of treatment on quality of life in neuroendocrine neoplasm survivors in Endocrine-Related Cancer. By Roberta Modica et al. Endocrine-Related Cancer.
ALT Endocrine-Related Cancer. Incoming Editor-in-Chief, Dr Karel Pacak. "It is a great honor to assume the role of Editor-in-Chief of Endocrine-Related Cancer, a journal fully committed to raising awareness of endocrine cancers among healthcare providers by supporting excellence in basic and clinical research, high-quality studies, and evidence-based guidelines." Published by Bioscientifica. Society for Endocrinology.
ALT Endocrine-Related Cancer. New Open-Access Research: Plasma metabolomics for the preoperative diagnosis of parathyroid carcinoma. By Jinheng Xiao et al. Published by Bioscientifica. Society for Endocrinology.
ALT Endocrine-Related Cancer logo. Text reads: Identification of protein-coding genes associated with metastatic prostate cancer. Published by bioscientifica logo and Society for Endocrinology logo. Circle text box reads: NEW RESEARCH. Open access logo.
ALT Text in top left reads Endocrine-Related Cancer. Central image of phone with Endocrine-Related Cancer Bluesky profile. Left-hand side of image features Bluesky logo repeated 4 times in varying positions.
ALT Quote from Editor-in-Chief, Dr Matthew Ringel: "On behalf of the Editorial board and team, I am very pleased that the Endocrine-Related Cancer Impact Factor has increased again this year. The new impact factor places Endocrine-Related Cancer in the top quartile in both the Endocrinology and Metabolism and Oncology categories, demonstrating the unique role Endocrine-Related Cancer plays in publishing impactful original science and review manuscripts in endocrine oncology."
